Kursprognose für Clearmind Medicine Inc (CMND)CMNDClearmind Medicine Inc

Alphio's CMND stock price prediction model matches the current Clearmind Medicine Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.58 (-0.05%). The 1-week path is $5.71 (+2.35%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Clearmind Medicine Inc. is not a good buy right now due to its significant financial losses and negative momentum. The current price is $5.58, which is down 96.49% year-to-date and 99.74% over the past year. The RSI is at 28.128, indicating that the stock is oversold, but this does not guarantee a price rebound. The company has reported a net income loss of $3,854,583 in Q1 2026 and has a forward P/E ratio of 0, indicating no expected earnings growth in the near future. The main risk is the ongoing financial losses, with a gross profit of -$14,218 in Q3 2026, suggesting that the company is struggling to generate revenue. Until there are clear signs of recovery or positive earnings, it is advisable to avoid this stock.

Clearmind Medicine Inc (CMND) last closed at $5.5799999, losing -4.62%. These facts feed the 1-day and 1-week CMND price prediction above.